BioNTech Gets Green Light to Start Coronavirus Vaccine Trials in Germany [The Motley Fool]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: The Motley Fool
Cory Renauer(TMFang4apples)Author BioCory is a long-term minded analyst focused on the Healthcare Sector. He genuinely enjoys cutting through the complexity to help everyday investors make better decisions.Follow @coryrenauerFollow @@coryrenauerGermanimmunotherapyBioNTech SENASDAQ:BNTXPfizerNYSE:PFEIt was just over a month ago, on March 7, that Pfizer and BioNTech agreed to join forces to attempt to develop a vaccine for SARS-CoV-, the coronavirus that causes COVID-9. Now, the Paul-Ehrlich-Institut -- which is both a research institute and one of Germany's medical regulators -- has given them the go-ahead to conduct human studies of the experimental vaccines from theirBNT6 programImage source: Getty Images.TheantigensA good dealOn April 9, Pfizer handed BioNTech an upfront payment of $85 million and promised it up to $56 million in potential milestone payments. If the BNT6 program produces a successful vaccine, the partners will split the costs of development and commercialization. If
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pfizer (PFE) CEO Isn't Ready For A Fight With RFK Jr., Says Jim Cramer [Yahoo! Finance]Yahoo! Finance
- Trump's New Prescription Plan vs. Mark Cuban's: Experts Weigh In [Yahoo! Finance]Yahoo! Finance
- Small Molecule API Market Size to Reach USD 328.03 Billion by 2033, Driven by Rising Demand for Cost-Effective Therapeutics – SNS Insider [Yahoo! Finance]Yahoo! Finance
- What's in the Trump health care plan? White House releases blueprint. [USA TODAY]USA TODAY
- Why Pfizer Inc. (PFE) is One of the Best Affordable Stocks Under $30 [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 11/4/25 - Beat
PFE
Sec Filings
- 1/16/26 - Form 4
- 1/5/26 - Form 4
- 1/5/26 - Form 4
- PFE's page on the SEC website